Publications:

Defining the transcriptional control of pediatric AML highlights RARA as a superenhancer-regulated druggable dependency.

Blood Advances

Perez, Monika W MW; Sias-Garcia, Oscar O; Daramola, Alfred A; Wei, Helen H; Terrell, Maci M; Rashid, Raushan R; Park, Woojun D WD; Duong, Kevin K; Horton, Terzah M TM; Li, Feng F; Cherayil, Nikitha N; Koren, Jost Vrabic JV; Gant, Vincent U VU; Junco, Jacob J JJ; Curry, Choladda V CV; Stevens, Alexandra M AM; Lin, Charles Y CY; Yi, Joanna S JS

Publication Date: 2021-12-14

Variant appearance in text: RARA: G12D

PubMed Link: 34543389

Variant Present in the following documents:

• advancesADV2020003737.pdf

View BVdb publication page

Nrf2 and Notch Signaling in Lung Cancer: Near the Crossroad.

Oxidative Medicine And Cellular Longevity

Sparaneo, Angelo A; Fabrizio, Federico Pio FP; Muscarella, Lucia Anna LA

Publication Date: 2016

Variant appearance in text: RAR-alpha: G12D

PubMed Link: 27847554

Variant Present in the following documents:

• OMCL2016-7316492.pdf

View BVdb publication page

Is PML a Tumor Suppressor?

Frontiers In Oncology

Mazza, Massimiliano M; Pelicci, Pier Giuseppe PG

Publication Date: 2013

Variant appearance in text: RARA: G12D

PubMed Link: 23847764

Variant Present in the following documents:

• Main text

View BVdb publication page